CMS faces renewed legal pressure on drug price negotiation program
Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction Act (IRA). | A new lawsuit from a drug manufacturer,
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of
Xifaxan selected for CMS drug price talks in 2027
LAVAL, QC - Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a pharmaceutical company with a market capitalization of $2.81 billion and impressive revenue growth of 10.91% over the last twelve months,
Teva sues CMS over Medicare drug price negotiations
Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked price-setting power. Read more here.
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare's next round of drug negotiations
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025.
ENDPOINTS NEWS1d
What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions
CMS didn't wait for President-elect Donald Trump to take office before issuing its second list of drugs to be negotiated ...
Fierce Healthcare2d
Alignment Healthcare sues CMS over star ratings, disapproves of federal contractor's role
Alignment Healthcare is the latest Medicare Advantage (MA) insurer to accuse the Centers for Medicare & Medicaid Services ...
aha.org1d
CMS says record 24.2 million enrolled in Marketplace coverage for 2025
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
Modern Healthcare3d
CMS retracts Medicare Advantage enrollment report
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
McKnight's Long-Term Care News4d
CMS locks in 2025 nursing home surveyor priorities
CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.
STAT2d
How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
JD Supra3d
Understanding CMS “Immediate Jeopardy” Investigations in Healthcare Facilities
When it comes to ensuring patient safety, healthcare facilities operate under a complex regulatory framework, including ...
Health Affairs4d
Innovation At CMS: Advancing A Person-Centered Health System
The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding ...
Healthcare Dive5d
CMS proposes Medicare Advantage payment hike in 2026
The Biden administration’s last MA rule is a boon for insurers, though it remains to be seen how the incoming Trump ...
Kolkata RG Kar Doctor Case Court Verdict Live Updates: Kolkata court pronounces accused Sanjay Roy guilty, sentencing on January 20
In a significant development, the Additional District Judge at Sealdah Court has found accused Sanjay Roy guilty in the RG ...